Topical composition for skin, agent for promoting skin permeability of hyaluronic acid, and method for promoting skin permeability of hyaluronic acid

A skin composition with hyaluronic acid fermented products and derivatives with low molecular weight enhances skin permeability, addressing the penetration challenge and improving skin feel.

JP2024159327APending Publication Date: 2024-11-08ROHTO PHARM CO LTD
View PDF 15 Cites 0 Cited by

Patent Information

Application Number
JP2023075256
Authority / Receiving Office
JP · JP
Patent Type
Applications
Current Assignee / Owner
Filing Date
2023-04-28
Publication Date
2024-11-08

AI Technical Summary

Technical Problem

Hyaluronic acid, due to its high molecular weight, has difficulty penetrating the skin effectively, limiting its functional efficacy in external skin preparations.

Method used

A skin external composition containing hyaluronic acid fermented products and derivatives or salts with a weight average molecular weight of 1.2 million or less, particularly using hyaluronic acid fermented by lactic acid cocci, along with components like hydrolyzed alkyl (C12-13) hyaluronate glyceryl hyaluronate and hydroxypropyltrimonium hyaluronate, to enhance skin permeability.

Benefits of technology

Significantly promotes the permeability of hyaluronic acid into the skin, providing enhanced softness and moisturizing sensations.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure 2024159327000004
    Figure 2024159327000004
  • Figure 2024159327000005
    Figure 2024159327000005
  • Figure 2024159327000006
    Figure 2024159327000006
Patent Text Reader

Abstract

To improve the skin permeability of hyaluronic acid, specifically, to provide a topical composition for skin with improved skin permeability of hyaluronic acid, and further to provide a topical composition for skin that facilitates the deeper penetration of hyaluronic acid into the skin, offering an improved user experience such as enhanced skin softness and enriched hydration.SOLUTION: A topical composition for skin contains (A) a hyaluronic acid fermented product and (B) hyaluronic acid, a hyaluronic acid derivative, or a salt thereof with a weight average molecular weight of 1,200,000 or less.SELECTED DRAWING: None
Need to check novelty before this filing date? Find Prior Art

Description

[Technical field]

[0001] The present invention relates to a composition for external use on the skin, a skin permeation enhancer for hyaluronic acid, and a method for enhancing skin permeation of hyaluronic acid. [Background technology]

[0002] Hyaluronic acid is a mucopolysaccharide with a linear structure of disaccharide units consisting of D-glucuronic acid and N-acetylglucosamine, and exists in large quantities in the dermis as a bonding substance between cells and fibers in the body, and is also present in the epidermis. Hyaluronic acid has high water retention and viscoelasticity, so it is widely used as a moisturizing agent in pharmaceuticals and cosmetics.

[0003] However, because hyaluronic acid has an extremely high molecular weight, when used as a skin topical agent component, it is difficult to penetrate the skin, and may not be able to fully demonstrate its function in practical use. Therefore, in attempts to improve the percutaneous absorption of hyaluronic acid, attempts have been made to reduce the molecular weight of hyaluronic acid (Patent Document 1: JP 2002-533376 A), to blend an amphoteric surfactant with hyaluronic acid (Patent Document 2: WO 2022 / 259901), and to use electrolytes such as sodium chloride to seemingly neutralize the negative charge of hyaluronic acid and predominate hydrogen bonds, thereby suppressing the spread of hyaluronic acid molecules and forming fine particles (Patent Document 3: WO 2021 / 033725). However, the effects of these attempts are not sufficient. [Prior art documents] [Patent documents]

[0004] [Patent Document 1] Special Publication No. 2002-533376 [Patent Document 2] International Publication No. 2022 / 259901 [Patent Document 3] International Publication No. 2021 / 033725 Summary of the Invention [Problem to be solved by the invention]

[0005] In this situation, the present invention aims to improve the skin permeability of hyaluronic acid, specifically, to provide a skin composition for external use that improves the skin permeability of hyaluronic acid.Furthermore, the present invention aims to provide a skin composition for external use that is excellent in the feeling of use, such as skin softness and moisturizing feeling, because hyaluronic acid penetrates deeper into the skin. [Means for solving the problem]

[0006] The present inventors have conducted intensive research to solve the above-mentioned problems, and have found that a skin topical composition containing hyaluronic acid fermentation product by microorganisms and hyaluronic acid, hyaluronic acid derivative, or salt thereof (hereinafter also referred to as "hyaluronic acids") of a specific size is significantly promoted when the composition is applied to the skin, and the skin is soft and moisturized, and other usability is excellent, and thus the present invention has been completed. That is, the gist of the present invention to solve the above-mentioned problems is as follows.

[0007] [1] A composition for external skin application containing (A) a hyaluronic acid fermentation product and (B) hyaluronic acid, a hyaluronic acid derivative, or a salt thereof having a weight-average molecular weight of 1.2 million or less. [2] (A) The topical skin composition described in [1], wherein the hyaluronic acid fermentation product is a fermentation product of hyaluronic acid by lactic acid bacteria. [3] The topical skin composition described in [1] or [2], which contains at least hydrolyzed alkyl (C12-13) glyceryl hyaluronate, hydroxypropyltrimonium hyaluronate, and sodium acetylated hyaluronate as component (B). [4] A skin penetration enhancer for hyaluronic acid, a hyaluronic acid derivative, or a salt thereof, comprising (A) a hyaluronic acid fermentation product, and (B) hyaluronic acid, a hyaluronic acid derivative, or a salt thereof having a weight-average molecular weight of 1.2 million or less. [5] (A) A skin penetration enhancer described in [4], wherein the hyaluronic acid fermentation product is a fermentation product of hyaluronic acid by lactic acid bacteria. [6] A method for promoting skin penetration of hyaluronic acid, a hyaluronic acid derivative, or a salt thereof, comprising using (A) a hyaluronic acid fermentation product, and (B) hyaluronic acid, a hyaluronic acid derivative, or a salt thereof having a weight-average molecular weight of 1.2 million or less. [7] The method for promoting skin penetration described in [6], wherein (A) the hyaluronic acid fermentation product is a fermentation product of hyaluronic acid by lactic acid bacteria. [8] (A) A skin penetration enhancer for hyaluronic acid, a hyaluronic acid derivative, or a salt thereof, comprising a hyaluronic acid fermentation product. [9] (A) The skin penetration enhancer described in [8], wherein the hyaluronic acid fermentation product is a fermentation product of hyaluronic acid by lactic acid bacteria.

[10] (A) A method for promoting skin penetration of hyaluronic acid, a hyaluronic acid derivative, or a salt thereof, characterized by using a hyaluronic acid fermentation product.

[11] The method for promoting skin penetration described in

[10] , wherein (A) the hyaluronic acid fermentation product is a fermentation product of hyaluronic acid by lactic acid bacteria. Effect of the Invention

[0008] The topical skin composition of the present invention contains (A) a hyaluronic acid fermentation product, and (B) hyaluronic acid, a hyaluronic acid derivative, or a salt thereof having a weight-average molecular weight of 1.2 million or less, and thus can significantly promote the permeability of the hyaluronic acid, the hyaluronic acid derivative, and / or a salt thereof into the skin, and also provides an excellent feel when used, such as skin softness and moisturization. [Brief description of the drawings]

[0009] [Figure 1-1] FIG. 1-1 is a fluorescence microscope image of a skin tissue fragment after test solution 1-1 containing fluorescently labeled hydrolyzed hyaluronic acid (weight average molecular weight: 10,000) was applied to a three-dimensional cultured skin model. [Figure 1-2]Figure 1-2 is a fluorescence microscope image of a skin tissue fragment after test solution 1-2, which contains fluorescently labeled hydrolyzed hyaluronic acid (weight average molecular weight 10,000) as well as hyaluronic acid fermentation product, was applied to a three-dimensional cultured skin model. [Figure 2-1] Figure 2-1 is a fluorescence microscope image of a skin tissue fragment after test solution 2-1 containing fluorescently labeled hydrolyzed hyaluronate alkyl (C12-13) glyceryl (weight average molecular weight 10,000) was applied to a three-dimensional cultured skin model. [Figure 2-2] Figure 2-2 is a fluorescence microscope image of a skin tissue fragment after test solution 2-2, which contains fluorescently labeled hydrolyzed hyaluronate alkyl (C12-13) glyceryl (weight average molecular weight 10,000) plus hyaluronic acid fermentation product, was applied to a 3D cultured skin model. [Figure 3-1] FIG. 3-1 is a fluorescence microscope image of a skin tissue fragment after test solution 3-1 containing fluorescently labeled sodium hyaluronate (weight average molecular weight 1.2 million) was applied to a three-dimensional cultured skin model. [Figure 3-2] Figure 3-2 is a fluorescence microscope image of a skin tissue fragment after test solution 3-2, which contains fluorescently labeled sodium hyaluronate (weight average molecular weight 1.2 million) as well as hyaluronic acid fermentation product, was applied to a three-dimensional cultured skin model. DETAILED DESCRIPTION OF THE PREFERRED EMBODIMENTS

[0010] The present invention will be described in detail below.

[0011] <Skin external composition> The skin topical composition of the present invention is a skin topical composition containing (A) hyaluronic acid fermentation product, and (B) hyaluronic acid, hyaluronic acid derivatives, or salts thereof having a weight-average molecular weight of 1.2 million or less ("(B) hyaluronic acids"). The skin topical composition of the present invention contains (A) hyaluronic acid fermentation product, and (B) hyaluronic acids, which can significantly promote the permeability of hyaluronic acid, hyaluronic acid derivatives, and / or salts thereof into the skin, and can also provide excellent skin softness, moisturizing, and other usability. In addition to (A) hyaluronic acid fermentation product and (B) hyaluronic acids, the skin topical composition of the present invention may contain various optional components within a range that does not impair the effects of the present invention, or for the purpose of improving the effects of the present invention. Each component contained in the skin topical composition of the present invention will be described in detail below.

[0012] In addition, the composition for external skin application of the present invention can also be said to be a blend of (A) a hyaluronic acid fermentation product and (B) hyaluronic acids.

[0013] In the present invention, hyaluronic acid refers to a mucopolysaccharide in which disaccharides consisting of N-acetylglucosamine and D-glucuronic acid (GlcNAcβ1-4GlcAβ1-3) are linked in a linear chain, and is distinguished from salts thereof.

[0014] In the present invention, the salt of hyaluronic acid may be any salt that is pharmacologically or physiologically acceptable, and can be exemplified by the salt with alkali metal such as sodium and potassium, the salt with alkaline earth metal such as calcium and magnesium, the salt with metal such as zinc and aluminum, ammonium salt, basic amino acid salt, amine salt such as triethanolamine, etc. Among them, sodium salt, potassium salt, zinc salt, and ammonium salt are preferred, and sodium salt and ammonium salt are more preferred.

[0015] In the present invention, hyaluronic acid derivative refers to a compound that, when hyaluronic acid is considered as a parent, is modified to such an extent that the structure or properties of the parent are not significantly changed, such as by introducing functional groups, oxidation, reduction, atom substitution, etc. Examples of hyaluronic acid derivative include acetylated hyaluronic acid, sulfated hyaluronic acid, hydrophobized hydrolyzed hyaluronic acid (hydrolyzed alkyl hyaluronate, hydrolyzed glyceryl hyaluronate, etc.), crosslinked hyaluronic acid, carboxymethyl hyaluronic acid, alkylene glycol hyaluronate, silanol hyaluronate, cationized hyaluronic acid, etc.

[0016] In the present invention, the salt of hyaluronic acid derivative may be any salt that is pharmacologically or physiologically acceptable, and can be, for example, the salt with alkali metal such as sodium and potassium; the salt with alkaline earth metal such as calcium and magnesium; the salt with metal such as zinc and aluminum; ammonium salt; basic amino acid salt; amine salt such as triethanolamine, etc. Among them, sodium salt, potassium salt, zinc salt, and ammonium salt are preferred, and sodium salt and ammonium salt are more preferred.

[0017] In the present invention, hyaluronic acid, salts of hyaluronic acid, hyaluronic acid derivatives, and salts of hyaluronic acid derivatives are sometimes referred to as "hyaluronic acids".

[0018] [(A) Hyaluronic acid fermentation product] The hyaluronic acid fermentation product (A) contained in the composition for external skin application of the present invention refers to a product obtained by fermenting hyaluronic acid, a hyaluronic acid derivative, and / or a salt thereof with a microorganism.

[0019] The microorganisms used in the fermentation are not particularly limited, but examples thereof include lactic acid bacteria, yeast, koji mold, and Bacillus subtilis.

[0020] Examples of the lactic acid bacteria include lactic acid cocci and lactic acid bacilli. Specific examples of the lactic acid bacteria include lactic acid bacteria of the genus Leuconostoc, such as Leuconostoc mesenteroides, Leuconostoc lactis, and Leuconostoc citreum; lactic acid bacteria of the genus Lactobacillus, such as Lactobacillus plantarum, Lactobacillus brevis, Lactobacillus casei, and Lactobacillus delbrueckii; lactic acid bacteria of the genus Lactobacillus, such as Carnobacterium divergens and Carnobacterium pisicola. Lactic acid bacteria of the genus Carnobacterium such as Streptococcus faecalis and Streptococcus pyogenes; lactic acid bacteria of the genus Enterococcus such as Enterococcus caseliflavus and Enterococcus sulfreus; lactic acid bacteria of the genus Lactococcus such as Lactococcus plantarum, Lactococcus lactis, and Lactococcus rafinolactis; lactic acid bacteria of the genus Lactococcus such as Weissella confusa and Weissella candoureri. Lactic acid bacteria of the genus Veicella, such as Atopobium kandleri; lactic acid bacteria of the genus Atopobium, such as Atopobium minutum and Atopobium parvulus;Examples of lactic acid bacteria include Vagococcus genus lactic acid bacteria such as Vagococcus fluvialis and Vagococcus salmoninarum; Pediococcus genus lactic acid bacteria such as Pediococcus damnosus and Pediococcus pentosaceus.

[0021] Examples of the yeast include yeasts of the genus Saccharomyces, such as Saccharomyces cerevisiae, Saccharomyces awamori, Saccharomyces chevalieri, Saccharomyces carlsbergensis, and Saccharomyces bayonus; yeasts of the genus Galactomyces; yeasts of the genus Torulaspora, such as Torulaspora delbruekii, Torulaspora fermentati, and Torulaspora rosei; yeasts of the genus Torulaspora, such as Zygosaccharomyces rouxii, Zygosaccharomyces Yeasts of the genus Zygosaccharomyces, such as Zygosaccharomyces soya, Zygosaccharomyces sake, Zygosaccharomyces miso, and Zygosaccharomyces lactis; yeasts of the genus Candida, such as Candida versatilis, Candida etchellsii, Candida kefyr, Candida sake, and Candida scottii; yeasts of the genus Candida, such as Aureobasidium Pullulans, Aureobasidium mansonii, and Aureobasidium Examples of yeasts of the genus Aureobasidium include Aureobasideium microstictum. The yeast according to the present invention may be any of sake yeast, wine yeast, brewer's yeast, yeast derived from plant flowers (rose, plum, cherry, camellia, lily, etc.), and yeast derived from the sea.

[0022] Examples of the koji mold include yellow koji molds such as Aspergillus oryzae, Aspergillus flavus, Aspergillus polyoxogenes, and Aspergillus sojae; black koji molds such as Aspergillus awamori, Aspergillus kawauchii, Aspergillus usami, and Aspergillus niger; and red koji molds such as Monascus anka and Monascus pilosus.

[0023] Examples of the Bacillus subtilis include Bacillus natto, Bacillus subtilis, and Bacillus circulans.

[0024] In the present invention, the microorganisms used in the above fermentation are preferably lactic acid bacteria and yeast, more preferably lactic acid bacteria, and even more preferably lactococci.

[0025] In preparing the hyaluronic acid fermentation product (A) of the present invention, it is preferable to sterilize hyaluronic acid, hyaluronic acid derivatives and / or their salts before the fermentation process in which the hyaluronic acid, hyaluronic acid derivatives and / or their salts are fermented by microorganisms to remove unwanted bacteria that hinder fermentation.The method for sterilizing and removing the unwanted bacteria is not particularly limited, and the fermentation material may be sterilized by heat sterilization or the like.The heat sterilization treatment generally uses heat sterilization methods such as the autoclave sterilization method in which the fermentation material is heated at 120-130°C for 10-20 minutes, or the intermittent sterilization method in which the fermentation material is held at 80-90°C for 60-120 minutes and is repeated once a day for 2-3 days.

[0026] During the above fermentation, sugars such as glucose, galactose, fructose, sucrose, maltose, lactose, etc. may be added as a carbon source.

[0027] The fermentation material and medium that have been sterilized by removing unwanted bacteria as described above are placed in a fermentation tank or the like, and the above-mentioned microorganisms are inoculated therein to cause fermentation. The amount of the microorganism to be inoculated can be adjusted as appropriate, but it is usually 10 6 ~10 9 10 7 ~10 8 If the inoculum amount is more than the above range, the fermentation time is almost unchanged, whereas if the inoculum amount is less than the above range, it takes a long time to complete the fermentation, which is not preferable.

[0028] The temperature during the fermentation may be within the optimum temperature range for growth of each microorganism, and is generally within the range of 5 to 50° C. The number of days for fermentation at the optimum temperature is generally 1 to 10 days, and preferably within the range of 2 to 5 days. If the number of days for fermentation is shorter than the above general range, the fermentation does not proceed sufficiently and the effectiveness of the fermented product tends to decrease, while if the number of days is longer than 10 days, not only is there no increase in effectiveness, but coloring and an increase in fermentation odor occur, which is not preferable.

[0029] As the (A) hyaluronic acid fermentation product of the present invention, after the above-mentioned fermentation process, the fermentation product that is collected from fermentation tank or the like can be used as it is, or the fermentation liquid that is removed microorganisms and other contaminants by centrifugal separation or the like can be used, but the fermentation liquid that is removed microorganisms and other contaminants is preferred.In addition, the form of the (A) hyaluronic acid fermentation product can be liquid, or can be liquid that is dried to be solid.

[0030] (A) The hyaluronic acid, hyaluronic acid derivatives, or salts thereof used as fermentation materials when preparing hyaluronic acid fermentation products may be natural hyaluronic acid extracted and recovered from animal tissues such as cockscomb, shark skin, umbilical cord, eyeball, skin, cartilage, etc., hyaluronic acid-producing microorganisms such as Streptococcus genus microorganisms, animal cells, or plant cell cultures, or may be decomposed hyaluronic acid obtained by decomposing the natural hyaluronic acid. The decomposed hyaluronic acid may be prepared, for example, by hydrolysis in the presence of acid or alkali, enzyme treatment such as hyaluronidase, or physical cutting such as ultrasonic wave or shearing. The fermentation materials may be various hyaluronic acid derivatives derived from the natural hyaluronic acid or decomposed hyaluronic acid, or may be salts thereof.

[0031] (A) Hyaluronic acid fermentation products are obtained by fermenting hyaluronic acid, hyaluronic acid derivatives and / or their salts as the fermentation materials with microorganisms, and therefore are thought to contain decomposed hyaluronic acids of various sizes.

[0032] The content of (A) hyaluronic acid fermentation product in the skin external composition of the present invention is 0.0001% by mass or more, preferably 0.0005% by mass or more, more preferably 0.001% by mass or more, even more preferably 0.05% by mass or more, and particularly preferably 0.1% by mass or more, based on the total amount of the skin external composition.In addition, the content of (A) hyaluronic acid fermentation product is 10% by mass or less, preferably 5.0% by mass or less, more preferably 3.0% by mass or less, even more preferably 1.0% by mass or less, and particularly preferably 0.8% by mass or less, based on the total amount of the skin external composition. The content of (A) hyaluronic acid fermentation product in the skin external composition of the present invention is 0.0001% by mass or more and 10% by mass or less, preferably 0.0005% by mass or more and 10% by mass or less, more preferably 0.05% by mass or more and 5.0% by mass or less, even more preferably 0.1% by mass or more and 3.0% by mass or less, and particularly preferably 0.1% by mass or more and 1.0% by mass or less, based on the total amount of the skin external composition.By making the content of (A) hyaluronic acid fermentation product within the above range, the skin permeability of the hyaluronic acids contained in the skin external composition of the present invention can be significantly improved.

[0033] [(B) Hyaluronic acid, hyaluronic acid derivatives, or salts thereof having a weight-average molecular weight of 1.2 million or less] The skin topical composition of the present invention contains (A) the above-mentioned hyaluronic acid fermentation product, and (B) hyaluronic acid, hyaluronic acid derivative, or salt thereof, having a weight-average molecular weight of 1.2 million or less. The skin topical composition of the present invention can significantly improve the permeability of hyaluronic acid into the skin by blending (B) the above-mentioned hyaluronic acids together with (A) the hyaluronic acid fermentation product.

[0034] In the present invention, the weight average molecular weight is a value measured by size exclusion chromatography. The conditions are as follows: Column: TSKgel GMPWXL 7.8mm x 30cm (Tosoh Corporation) Column temperature: constant temperature around 40℃ Detector: Differential refractometer Mobile phase: 0.2mol / L NaCl Flow rate: 0.3mL / min Injection volume: 100μL Standard substance: Pullulan standard (STANDARD P-82, Showa Denko K.K.)

[0035] (B) Hyaluronic acids are explained below by dividing them into high molecular weight hyaluronic acid (weight average molecular weight of 50,000 or more) or its salt, low molecular weight hyaluronic acid (weight average molecular weight of less than 50,000) or its salt, and hyaluronic acid derivatives or its salt.

[0036] (High molecular weight hyaluronic acid or its salt) Hyaluronic acid is a type of acidic mucopolysaccharide, and is a polysaccharide containing disaccharides of glucuronic acid and N-acetylglucosamine as constituent units. Hyaluronic acid can be extracted and collected from animal tissues such as cockscomb, shark skin, umbilical cord, eyeball, skin, cartilage, and from cultures of hyaluronic acid-producing microorganisms such as Streptococcus genus microorganisms, animal cells, and plant cells. It can also be purchased commercially. As the polymeric hyaluronic acid having a weight-average molecular weight of 50,000 or more and 1.2 million or less, such natural hyaluronic acid can be used. The weight-average molecular weight of natural hyaluronic acid is about 500,000 to 7 million, so that one having the above size range can be used from that.

[0037] In addition, decomposed hyaluronic acid obtained by decomposing natural hyaluronic acid can also be used as long as it has a weight-average molecular weight of 50,000 or more and 1,200,000 or less. Decomposed hyaluronic acid can be prepared, for example, by hydrolysis in the presence of acid or alkali, enzyme treatment with hyaluronidase or the like, physical cutting such as ultrasonic waves or shearing, or fermentation by microorganisms. Commercially available products can also be used.

[0038] In the present invention, the weight-average molecular weight of polymeric hyaluronic acid or its salt is 50,000 or more, preferably 100,000 or more, more preferably 200,000 or more, even more preferably 300,000 or more, and even more preferably 500,000 or more.The weight-average molecular weight of polymeric hyaluronic acid or its salt can be, for example, 1.6 million or less, preferably 1.2 million or less, and more preferably 800,000 or less.The weight-average molecular weight of polymeric hyaluronic acid or its salt is 50,000 or more and 1.6 million or less, preferably 100,000 or more and 1.4 million or less, more preferably 200,000 or more and 1.2 million or less, and even more preferably 300,000 or more and 1.2 million or less.Within this range, when the skin external composition of the present invention is applied to the skin, the permeability of hyaluronic acid is significantly promoted, and the skin is excellent in the feeling of use such as softness and moisturizing feeling.

[0039] Examples of commercially available polymeric hyaluronic acid include sodium hyaluronate HA12N (trade name) (Shiseido Co., Ltd.; weight average molecular weight 1.1 to 1.6 million), sodium biohyaluronate SZE (trade name) (Shiseido Co., Ltd.; weight average molecular weight 1.1 to 1.6 million), hyaluronic acid FCH-120 (trade name) (Kikkoman Biochemifa Corporation; weight average molecular weight 1.0 to 1.4 million), hyaluronic acid HA-LQ (trade name) (Kewpie Corporation; weight average molecular weight 850,000 to 1.6 million), hyaluronic acid FCH-80 (trade name) (Kikkoman Biochemifa Corporation; weight average molecular weight 600,000 to 1 million), hyaluronic acid FCH-60 (trade name) (Kikkoman Biochemifa Corporation; weight average molecular weight 500,000 to 700,000), and hyaluronic acid FCH-SU (trade name) (Kikkoman Biochemifa Corporation; weight average molecular weight 500,000 to 110,000).

[0040] The salt of polymeric hyaluronic acid may be any one that is pharmacologically or physiologically acceptable, and can be, for example, the salt with alkali metal such as sodium and potassium; the salt with alkaline earth metal such as calcium and magnesium; the salt with metal such as zinc and aluminum; ammonium salt; basic amino acid salt; amine salt such as triethanolamine.Among them, alkali metal salt and metal salt are preferred, and sodium salt, potassium salt and zinc salt are particularly preferred.In addition, in polymeric hyaluronic acid, it is more preferred to use hyaluronic acid in salt state, because it is more stable than hyaluronic acid.

[0041] The polymeric hyaluronic acid or its salt may be used alone or in combination of two or more.

[0042] The content of polymeric hyaluronic acid or its salt is preferably 0.001% by mass or more, more preferably 0.005% by mass or more, more preferably 0.01% by mass or more, and even more preferably 0.02% by mass or more, based on the total amount of the composition for external use on skin.The content of polymeric hyaluronic acid or its salt is preferably 10% by mass or less, more preferably 1.0% by mass or less, more preferably 0.5% by mass or less, and even more preferably 0.3% by mass or less, based on the total amount of the composition for external use on skin.The content of polymeric hyaluronic acid or its salt is preferably 0.001% by mass or more and 10% by mass or less, more preferably 0.005% by mass or more and 1% by mass or less, more preferably 0.01% by mass or more and 0.5% by mass or less, and even more preferably 0.02% by mass or more and 0.3% by mass or less. Within this range, when the skin external composition of the present invention is applied to the skin, the permeability of hyaluronic acid is significantly promoted, and the skin is excellent in use feeling such as softness, moisturizing feeling, etc. When multiple kinds of polymeric hyaluronic acid or salts thereof are contained, the content of polymeric hyaluronic acid or salts thereof is the total content of them.

[0043] (Low molecular weight hyaluronic acid or its salt) As the low molecular weight hyaluronic acid having a weight average molecular weight of less than 50,000, the decomposition product of high molecular weight hyaluronic acid can be used. The low molecular weight hyaluronic acid can be obtained by hydrolyzing high molecular weight hyaluronic acid in the presence of an acid such as hydrochloric acid or an alkali, treating with an enzyme such as hyaluronidase, physically cutting with ultrasonic waves or shearing, or fermenting with a microorganism. When using hyaluronic acid oligosaccharide and / or its salt as the low molecular weight hyaluronic acid, it is preferable to use about 2 to 16 sugars, and either saturated or unsaturated type can be used. For example, there can be mentioned unsaturated hyaluronic acid in which a double bond is formed between the 4th and 5th positions of some or all of D-glucuronic acid.

[0044] In the present invention, the weight-average molecular weight of low molecular weight hyaluronic acid or its salt is less than 50,000, preferably 40,000 or less, more preferably 30,000 or less, and even more preferably 20,000 or less.In addition, the weight-average molecular weight of low molecular weight hyaluronic acid or its salt is preferably 100 or more, more preferably 200 or more, more preferably 500 or more, and even more preferably 1000 or more.In addition, the weight-average molecular weight of low molecular weight hyaluronic acid or its salt is preferably 100 or more and less than 50,000, more preferably 200 or more and 40,000 or less, more preferably 500 or more and 30,000 or less, and even more preferably 1000 or more and 20,000 or less.Within this range, when the skin external composition of the present invention is applied to the skin, the permeability of hyaluronic acid is significantly promoted, and the skin is excellent in the feeling of use such as softness and moisturizing feeling.

[0045] In the present invention, low molecular weight hyaluronic acid can also be purchased and used as commercially available products.As commercially available products of low molecular weight hyaluronic acid, can be mentioned Hyalooligo (trade name) (Kewpie Corporation; weight average molecular weight 10,000 or less), hyaluronic acid (SL) (trade name) (FAP Japan Co., Ltd.; weight average molecular weight 10,000 or less), micro hyaluronic acid FCH (trade name) (Kikkoman Biochemifa Corporation; weight average molecular weight 5000 or less), HAbooster (trade name) (Kewpie Corporation; weight average molecular weight 2000) etc.

[0046] The salt of low molecular weight hyaluronic acid may be any one that is pharmacologically or physiologically acceptable, and can be, for example, the salt with alkali metal such as sodium and potassium; the salt with alkaline earth metal such as calcium and magnesium; the salt with metal such as zinc and aluminum; ammonium salt; basic amino acid salt; amine salt such as triethanolamine, etc. Among them, alkali metal salt and metal salt are preferred, sodium salt, potassium salt and zinc salt are more preferred, and sodium salt is even more preferred.

[0047] The low molecular weight hyaluronic acid or its salt may be used alone or in combination of two or more.

[0048] The content of low molecular weight hyaluronic acid or its salt is preferably 0.0001% by mass or more, more preferably 0.001% by mass or more, more preferably 0.005% by mass or more, and even more preferably 0.01% by mass or more, based on the total amount of the skin external composition.In addition, the content of low molecular weight hyaluronic acid or its salt is preferably 20.0% by mass or less, more preferably 10.0% by mass or less, more preferably 5.0% by mass or less, and even more preferably 3.0% by mass or less, based on the total amount of the skin external composition.In addition, the content of low molecular weight hyaluronic acid or its salt in the skin external composition of the present invention is 0.0001% by mass or more and 20.0% by mass or less, preferably 0.001% by mass or more and 10.0% by mass or less, more preferably 0.005% by mass or more and 5.0% by mass or less, and particularly preferably 0.01% by mass or more and 3.0% by mass or less, based on the total amount of the skin external composition. By making the content of low molecular weight hyaluronic acid or its salt within the above-mentioned range, the skin permeability of the hyaluronic acid contained in the skin external composition of the present invention can be significantly improved.Note that, when containing multiple kinds of low molecular weight hyaluronic acid or its salt, the content of low molecular weight hyaluronic acid or its salt refers to the total content of them.

[0049] The content of hyaluronic acid or its salt in the skin external composition of the present invention (the total content of high molecular weight hyaluronic acid or its salt and low molecular weight hyaluronic acid or its salt) is preferably 0.0001% by mass or more, more preferably 0.005% by mass or more, even more preferably 0.01% by mass or more, and even more preferably 0.05% by mass or more, based on the total amount of the skin external composition.In addition, the content of hyaluronic acid or its salt is preferably 30% by mass or less, more preferably 20% by mass or less, even more preferably 10% by mass or less, and even more preferably 5.0% by mass or less, based on the total amount of the skin external composition. Furthermore, the content of hyaluronic acid or its salt in the skin external composition of the present invention is 0.0001% by mass or more and 30.0% by mass or less, preferably 0.005% by mass or more and 20.0% by mass or less, more preferably 0.01% by mass or more and 10% by mass or less, and even more preferably 0.05% by mass or more and 5.0% by mass or less, based on the total amount of the skin external composition.Within this range, when the skin external composition of the present invention is applied to skin, the permeability of hyaluronic acid is significantly promoted, and the skin is also excellent in the feeling of use such as softness and moisturizing feeling.

[0050] The content ratio of high molecular weight hyaluronic acid or its salt and low molecular weight hyaluronic acid or its salt in the skin external composition of the present invention can be 0.0001 parts by mass or more, 0.001 parts by mass or more, 0.01 parts by mass or more, 0.1 parts by mass or more, or 0.3 parts by mass or more, per 1 part by mass of high molecular weight hyaluronic acid or its salt.Also, it can be 1000 parts by mass or less, 50 parts by mass or less, 10 parts by mass or less, or 5 parts by mass or less.Within this range, when the skin external composition of the present invention is applied to skin, the permeability of hyaluronic acid is significantly promoted, and the feeling of use such as skin softness and moisturizing feeling is also excellent.

[0051] (Hyaluronic acid derivative or its salt) The hyaluronic acid derivative in the present invention is not particularly limited as long as it has a weight-average molecular weight of 1.2 million or less among hyaluronic acid derivatives, and examples thereof include acetylated hyaluronic acid, sulfated hyaluronic acid, hydrophobized hydrolyzed hyaluronic acid (hydrolyzed alkyl hyaluronate, hydrolyzed glyceryl hyaluronate, etc.), crosslinked hyaluronic acid, carboxymethyl hyaluronic acid, alkylene glycol hyaluronate, silanol hyaluronate, cationized hyaluronic acid, and salts thereof.

[0052] Among these, acetylated hyaluronic acid, hydroxypropyltrimonium hyaluronate, hydrolyzed alkyl hyaluronate (alkyl group having 12 to 13 carbon atoms; C12-13) glyceryl, crosslinked hyaluronic acid, carboxymethyl hyaluronic acid, propylene glycol hyaluronate, dimethylsilanol hyaluronate, and salts thereof are preferred, and acetylated hyaluronic acid, hydroxypropyltrimonium hyaluronate, hydrolyzed alkyl (C12-13) glyceryl hyaluronate, crosslinked hyaluronic acid, propylene glycol hyaluronate, dimethylsilanol hyaluronate, and salts thereof are more preferred.

[0053] Acetylated hyaluronic acid is preferably hyaluronic acid in which the hydroxyl groups are acetylated. Hyaluronic acid has four hydroxyl groups per structural unit (disaccharide), and the acetylated hyaluronic acid is preferably one in which 2 to 4 hydroxyl groups are acetylated.

[0054] Commercially available hyaluronic acid derivatives include acetylated sodium hyaluronate (trade name) (Shiseido Co., Ltd.; weight-average molecular weight of 10,000 to 100,000), Hyalobell (trade name) (Kewpie Corporation; weight-average molecular weight of 500,000 to 800,000), HyaloRepea (trade name) (Kewpie Corporation; weight-average molecular weight of 10,000 or less), Hyalocatch (trade name) (Kewpie Corporation; weight-average molecular weight of 800,000 to 1,200,000), Hyalujon (trade name) (Kikkoman Biochemifa Corporation; propylene glycol hyaluronate), DSHCN6 (trade name) (EXSYMOL SAM; dimethylsilanol hyaluronate), and DSHCN (trade name) (EXSYMOL SAM; dimethylsilanol hyaluronate).

[0055] The salt of hyaluronic acid derivative may be any one that is pharmacologically or physiologically acceptable, and can be exemplified by salts with alkali metals such as sodium and potassium; salts with alkaline earth metals such as calcium and magnesium; salts with metals such as zinc and aluminum; ammonium salts; basic amino acid salts; and amine salts such as triethanolamine.Among them, sodium salts, potassium salts, zinc salts, and ammonium salts are preferred, and sodium salts and ammonium salts are more preferred.The salt of hyaluronic acid derivative can be exemplified by sodium acetylated hyaluronate, potassium acetylated hyaluronate, calcium acetylated hyaluronate, magnesium acetylated hyaluronate, zinc acetylated hyaluronate, ammonium acetylated hyaluronate, sodium hyaluronate crosspolymer, and hydroxypropyltrimonium hyaluronate.

[0056] One or more types of hyaluronic acid derivatives can be used.

[0057] The content of hyaluronic acid derivative or its salt in the skin external composition of the present invention is preferably 0.0001% by mass or more, more preferably 0.001% by mass or more, more preferably 0.01% by mass or more, and even more preferably 0.1% by mass or more, based on the total amount of the skin external composition.In addition, the content of hyaluronic acid derivative or its salt is preferably 20.0% by mass or less, more preferably 10.0% by mass or less, more preferably 5.0% by mass or less, and even more preferably 3.0% by mass or less, based on the total amount of the skin external composition.In addition, the content of hyaluronic acid derivative or its salt in the skin external composition of the present invention is 0.0001% by mass or more and 20.0% by mass or less, preferably 0.001% by mass or more and 10.0% by mass or less, more preferably 0.01% by mass or more and 5.0% by mass or less, and particularly preferably 0.1% by mass or more and 3.0% by mass or less, based on the total amount of the skin external composition. By making the content of hyaluronic acid derivative or its salt within the above-mentioned range, the skin permeability of the hyaluronic acid, hyaluronic acid derivative and / or their salt contained in the skin external composition of the present invention can be significantly improved.Note that, when containing multiple kinds of hyaluronic acid derivative or its salt, the content of hyaluronic acid derivative or its salt refers to the total content of them.

[0058] In the skin external composition of the present invention, the (B) hyaluronic acid comprises at least 3 kinds selected from the group consisting of the above-mentioned hyaluronic acids, preferably comprises at least 4 kinds, more preferably comprises at least 5 kinds, and even more preferably comprises at least 6 kinds.The combination of (B) hyaluronic acid contained in the skin external composition of the present invention is not particularly limited, but preferred combinations include, for example, those that comprise the combination of hydrolyzed hyaluronic acid alkyl (C12-13) glyceryl, hydroxypropyltrimonium hyaluronate, and sodium acetylated hyaluronate, and those that comprise the combination of sodium hyaluronate (weight average molecular weight 1.2 million), hydrolyzed sodium hyaluronate (weight average molecular weight 10,000), and hydrolyzed hyaluronic acid alkyl (C12-13) glyceryl (weight average molecular weight 10,000).

[0059] The content of (B) hyaluronic acid in the skin external composition of the present invention is preferably 0.0001% by mass or more, more preferably 0.001% by mass or more, even more preferably 0.01% by mass or more, and even more preferably 0.1% by mass or more, based on the total amount of the skin external composition.The content of (B) hyaluronic acid is preferably 30.0% by mass or less, more preferably 20.0% by mass or less, even more preferably 10.0% by mass or less, and even more preferably 5.0% by mass or less, based on the total amount of the skin external composition.The content of (B) hyaluronic acid in the skin external composition of the present invention is 0.0001% by mass or more and 30.0% by mass or less, preferably 0.001% by mass or more and 20.0% by mass or less, more preferably 0.01% by mass or more and 10.0% by mass or less, and particularly preferably 0.05% by mass or more and 5.0% by mass or less, based on the total amount of the skin external composition. By making the content of (B) hyaluronic acid within the above range, the skin permeability of the hyaluronic acid, hyaluronic acid derivative and / or their salts contained in the skin topical composition of the present invention can be significantly improved.Note that, when the content of (B) hyaluronic acid contains multiple kinds of (B) hyaluronic acid, the content of (B) hyaluronic acid refers to the total content of them.

[0060] [solvent] The composition for external use on skin of the present invention contains water, alcohol, a hydrophilic organic solvent, a fatty acid, a higher fatty acid ester, a glyceride, or a hydrophobic organic solvent, or a miscible mixture thereof.

[0061] The solvent is preferably one that functions as a base or carrier in the topical skin composition of the present invention, and examples of the solvent include aqueous solvents such as water, hydrocarbons such as liquid paraffin, squalane, petrolatum, gelling hydrocarbons (such as Plastibase), ozokerite, α-olefin oligomers, and light liquid paraffin; methyl polysiloxanes such as polymethylsilsesquioxane, crosslinked methyl polysiloxanes, highly polymerized methyl polysiloxanes, cyclic silicones, alkyl-modified silicones, crosslinked alkyl-modified silicones, amino-modified silicones, polyether-modified silicones, polyglycerin-modified silicones such as lauryl dimethicone polyglycerin-3 crosspolymer, crosslinked polyether-modified silicones, crosslinked alkyl polyether-modified silicones, silicone / alkyl chain co-modified polyether-modified silicones, silicone / alkyl chain co-modified polyglycerin-modified silicones, polyether-modified branched silicones, and polyglycerin-modified branched silicones. Examples of suitable solvents include silicone oils such as silicone, acrylic silicone, phenyl-modified silicone, and silicone resin; higher alcohols such as cetanol, cetostearyl alcohol, stearyl alcohol, and behenyl alcohol; cellulose derivatives such as ethyl cellulose, hydroxypropyl cellulose, and hydroxypropyl methyl cellulose; polyvinylpyrrolidone; carrageenan; polyvinyl butyrate; polyethylene glycol; dioxane; butylene glycol adipate polyester; esters such as isopropyl myristate, octyldodecyl myristate, isopropyl palmitate, cetyl palmitate, octyl palmitate, isononyl isononanoate, pentaerythritol tetra-2-ethylhexanoate, glyceryl tri-2-ethylhexanoate, and jojoba oil; polysaccharides such as dextrin and maltodextrin; and alcohols such as ethanol and isopropanol. Among these, aqueous solvents are preferred, and water is particularly preferred. When the topical composition for skin of the present invention contains water, the amount of water can be selected as appropriate taking into consideration the feel on the skin when used and the effects of the present invention, and is, for example, 0.001% by mass to 99.99% by mass, preferably 0.01% by mass to 99.9% by mass, more preferably 0.1% by mass to 95% by mass, and most preferably 1% by mass to 90% by mass, based on the total amount of the topical composition for skin of the present invention.

[0062] [Oil content] The skin external composition of the present invention does not contain oil, or its content is 10% by mass or less based on the total amount of the skin external composition.The oil content is preferably 5% by mass or less based on the total amount of the skin external composition, more preferably 3% by mass or less, even more preferably 2% by mass or less, and even more preferably 1% by mass or less.This range is also preferable from the viewpoint of the permeability of the hyaluronic acid contained in the skin external composition of the present invention into the skin.

[0063] In the present invention, the oil is a liquid or fluid oily substance at 25°C. The oil in the present invention is preferably a liquid, fluid, or semi-solid oily substance at 25°C, and more preferably a liquid, fluid, semi-solid, or solid oily substance at 25°C. Solid means that it has no fluidity at 25°C, semi-solid means that it has a melting point of 25°C to 45°C, and liquid means that it has fluidity at 25°C. Examples of oily substances include hydrocarbons, waxes, silicones, higher alcohols, higher fatty acids, oils and fats, and esters. These oily substances are blended for purposes different from those of the above-mentioned solvent.

[0064] Examples of the hydrocarbons include liquid paraffin, liquid isoparaffin, squalane, petrolatum, paraffin, microcrystalline wax, polybutene, polyethylene powder, gelled hydrocarbons (such as Plastibase), ozokerite, α-olefin oligomers, light liquid paraffin, light iso liquid paraffin, isododecane, isohexadecane, etc. Among these, liquid paraffin, liquid isoparaffin, squalane, petrolatum, gelled hydrocarbons (such as Plastibase), α-olefin oligomers, light liquid paraffin, and light iso liquid paraffin are preferred, and liquid paraffin, liquid isoparaffin, squalane, α-olefin oligomers, light liquid paraffin, and light iso liquid paraffin are more preferred.

[0065] Examples of waxes include jojoba oil, beeswax, candelilla wax, rice bran wax, cotton wax, carnauba wax, lanolin, liquid lanolin, reduced lanolin, etc. Among these, jojoba oil, beeswax, candelilla wax, and rice bran wax are preferred, and jojoba oil is particularly preferred.

[0066] Examples of silicones include methyl polysiloxane, crosslinked methyl polysiloxane, highly polymerized methyl polysiloxane, phenyl-modified silicones such as methylphenyl polysiloxane, cyclic silicones such as decamethylcyclopentasiloxane, methyl hydrogen polysiloxane, alkyl-modified silicones such as methyl trimethicone, dimethiconol, dimethiconol crosspolymer, and caprylyl methicone, crosslinked alkyl-modified silicones, amino-modified silicones, polyether-modified silicones, polyglycerin-modified silicones, crosslinked polyether-modified silicones, crosslinked alkyl polyether-modified silicones, silicone / alkyl chain co-modified polyether-modified silicones, silicone / alkyl chain co-modified polyglycerin-modified silicones, polyether-modified branched silicones, polyglycerin-modified branched silicones, acrylic silicones, phenyl-modified silicones, and silicone resins. Among these, methyl polysiloxane, crosslinked methyl polysiloxane, highly polymerized methyl polysiloxane, methylphenyl polysiloxane, and decamethylcyclopentasiloxane are preferred.

[0067] Examples of higher alcohols include saturated or unsaturated, linear or branched higher alcohols having 8 to 22 carbon atoms. Specific examples include capryl alcohol, lauryl alcohol, myristyl alcohol, cetanol, cetostearyl alcohol, stearyl alcohol, behenyl alcohol, octyldodecanol, isostearyl alcohol, phytosterol, cholesterol, oleyl alcohol, etc. Among these, cetanol, cetostearyl alcohol, stearyl alcohol, behenyl alcohol, octyldodecanol, and isostearyl alcohol are preferred, and octyldodecanol and isostearyl alcohol are more preferred.

[0068] Examples of higher fatty acids include saturated or unsaturated, linear or branched higher alcohols having 8 to 22 carbon atoms. Specific examples include caprylic acid, capric acid, lauric acid, myristic acid, palmitic acid, palmitoleic acid, stearic acid, oleic acid, linoleic acid, linolenic acid, and behenic acid. Among these, isostearic acid, stearic acid, and behenic acid are preferred, and isostearic acid is more preferred.

[0069] Examples of fats and oils include avocado oil, linseed oil, camellia oil, macadamia nut oil, kukui nut oil, hazelnut oil, corn oil, olive oil, safflower oil, apricot kernel oil, cinnamon oil, jojoba oil, grape seed oil, sunflower oil, almond oil, meadowfoam oil, camellia oil, rapeseed oil, sesame oil, cacao butter, coconut oil, hardened coconut oil, palm oil, palm kernel oil, Japan wax kernel oil, Japan wax, wheat germ oil, rice germ oil, rice bran oil, cottonseed oil, soybean oil, peanut oil, tea seed oil, evening primrose oil, shea butter, hardened oil, orange roughy oil, and horse oil. Among these, avocado oil, macadamia nut oil, olive oil, grape seed oil, sunflower oil, almond oil, meadowfoam oil, sesame oil, palm oil, palm kernel oil, rice germ oil, rice bran oil, soybean oil, evening primrose oil, shea butter, and orange roughy oil are preferred.

[0070] Esters include isopropyl myristate, octyldodecyl myristate, isopropyl palmitate, cetyl palmitate, isononyl isononanoate, diisopropyl adipate, decyl oleate, oleyl oleate, isodecyl oleate, hexyldecyl dimethyloctanoate, diisopropyl sebacate, di-2-ethylhexyl sebacate, 2-hexyldecyl myristate, 2-ethylhexyl palmitate, diisopropyl adipate, isotridecyl isononanoate, Cetyl lactate, isostearyl isostearate, cholesteryl 12-hydroxystearate, cholesteryl stearate, cholesteryl oleate, phytosteryl macadamiate, phytosteryl oleate, dextrin palmitate, inulin stearate, hydrogenated jojoba oil, ethylene glycol di-2-ethylhexylate, dipentaerythritol fatty acid ester, neopentyl glycol dicaprate, tri-2-ethylhexyl trimellitate, tridecyl trimellitate , trimethylolpropane tri-2-ethylhexyl, trimethylolpropane triisostearate, pentaerythritol tetra-2-ethylhexanoate, glycerin tri-2-ethylhexanoate, trimethylolpropane triisostearate, polyglyceryl diisostearate, polyglyceryl monoisostearate, caprylic / capric triglyceride, caprylic / capric / myristic / stearic triglyceride, oleyl oleate, lauroyl Examples of suitable glyceryl / isostearyl / cetyl / behenyl dimer dilinoleate include phytosteryl / octyldodecyl glutamate, phytosteryl / octyldodecyl / phytosteryl / behenyl lauroyl glutamate, triethyl citrate, phytosteryl / isostearyl / cetyl / stearyl / behenyl dimer dilinoleate, dimer dilinoleyl dimer dilinoleate, dipentaerythrityl tri-polyhydroxystearate, glyceryl tri(behenate / isostearate / eicosandioate), diisostearyl malate, and triethyl citrate.Among them, isopropyl myristate, octyldodecyl myristate, isopropyl palmitate, isononyl isononanoate, oleyl oleate, diisopropyl sebacate, di-2-ethylhexyl sebacate, 2-ethylhexyl palmitate, diisopropyl adipate, isotridecyl isononanoate, isostearyl isostearate, cholesteryl 12-hydroxystearate, cholesteryl stearate, cholesteryl oleate, phytosteryl macadamiate, phytosteryl oleate, dextrin palmitate, inulin stearate, hydrogenated jojoba oil, ethylene glycol di-2-ethylhexylate, dipentaerythritol fatty acid ester, neopentyl glycol dicaprate, tri-2-ethylhexyl trimellitate, tritridecyl trimellitate, trimethylolpropane tri-2-ethylhexylate, triisostearate ... Trimethylolpropane tearic acid, pentaerythritol tetra-2-ethylhexanoate, glycerin tri-2-ethylhexanoate, trimethylolpropane triisostearate, polyglyceryl diisostearate, polyglyceryl monoisostearate, tri(caprylic acid / capric acid), tri(caprylic acid / capric acid / myristic acid / stearic acid)glyceryl, oleyl oleate, di(phytosteryl / octyldodecyl) lauroyl glutamate, di(octyldodecyl / phytosteryl / behenyl) lauroyl glutamate, triethyl citrate, dimer dilinoleate (phytosteryl / isostearyl / cetyl / stearyl / behenyl), dimer dilinoleate dimer dilinoleyl, dipentaerythrityl tripolyhydroxystearate, and tri(behenic acid / isostearic acid / eicosandioic acid)glyceryl are preferred.

[0071] In the composition for external use on skin of the present invention, one or more types of oils can be used.

[0072] [Optional ingredients] The skin topical composition of the present invention may contain vitamins, alkanediols, polyhydric alcohols, glycol ethers, thickeners, etc., in addition to the above-mentioned components (A) and (B) in order to improve the effects of the present invention. In addition, other components may be contained within a range that does not impair the effects of the present invention. Each of these components may be used alone, or two or more may be used in any combination. In addition, when the compounds specifically exemplified as each component overlap, it is sufficient that they are contained as either of the components.

[0073] (Vitamins) Examples of the vitamins include retinol derivatives such as retinol, retinol acetate, and retinol palmitate, vitamin A such as retinal, retinoic acid, methyl retinoate, ethyl retinoate, retinol retinoate, d-δ-tocopheryl retinoate, α-tocopheryl retinoate, and β-tocopheryl retinoate; provitamin A such as β-carotene, α-carotene, γ-carotene, δ-carotene, lycopene, zeaxanthin, cryptoxanthin, and echinenone; δ-tocopherol, Vitamin E such as α-tocopherol, β-tocopherol, dl-α-tocopherol succinate, dl-α-tocopherol calcium succinate, δ-tocopherol, and tocopherol nicotinate; Vitamin B2 such as riboflavin, flavin mononucleotide, flavin adenine dinucleotide, riboflavin butyrate, riboflavin tetrabutyrate, riboflavin 5'-phosphate sodium, and riboflavin tetranicotinate; methyl nicotinate, nicotinic acid, and nicotinamide. Nicotinic acid; vitamin C such as ascorbyl stearate, L-ascorbyl dipalmitate, ascorbyl tetraisopalmitate (ascorbyl tetra 2-hexyldecanoate), ascorbic acid, sodium ascorbate, dehydroascorbic acid, sodium ascorbyl phosphate, magnesium ascorbyl phosphate, ascorbyl glucoside, and 3-O-ethyl ascorbic acid; vitamin D such as methylhesperidin, ergocalciferol, and cholecalciferol; phylloxacin; Vitamin K such as non- and farnoquinone; Vitamin B1 such as dibenzoyl thiamine, dibenzoyl thiamine hydrochloride, thiamine hydrochloride, thiamine cetyl hydrochloride, thiamine thiocyanate, thiamine lauryl hydrochloride, thiamine nitrate, thiamine monophosphate, thiamine lysine salt, thiamine triphosphate, thiamine monophosphate ester, thiamine diphosphate ester, thiamine diphosphate ester hydrochloride, thiamine triphosphate ester, thiamine triphosphate ester monophosphate;Vitamin B6 such as pyridoxine hydrochloride, pyridoxine acetate, pyridoxal hydrochloride, 5'-pyridoxal phosphate, and pyridoxamine hydrochloride; vitamin B12 such as cyanocobalamin, hydroxocobalamin, and deoxyadenosylcobalamin; folic acids such as folic acid and pteroylglutamic acid; pantothenic acids such as pantothenic acid, calcium pantothenate, pantothenyl alcohol (panthenol), D-pantetheine, D-pantethine, coenzyme A, and pantothenyl ethyl ether; biotins such as biocytin; and vitamin-like action factors such as carnitine, ferulic acid, α-lipoic acid, orotic acid, and γ-oryzanol. Among these, vitamin C is preferred from the viewpoint of the effect of the skin external composition of the present invention. Among vitamin C, some of the vitamin C derivatives are converted into vitamin C by enzymes in the living body and act.

[0074] When vitamins are included, the amount used can be appropriately selected taking into consideration the feel when used, but is, for example, 0.001% by mass to 30% by mass, preferably 0.1% by mass to 25% by mass, and more preferably 0.5% by mass to 20% by mass, based on the total amount of the topical skin composition of the present invention.

[0075] (Alkanediol) The skin topical composition of the present invention may contain an alkanediol having 5 to 10 carbon atoms. The alkanediol preferably has 5 to 10 carbon atoms, more preferably has 5 to 8 carbon atoms, and even more preferably has 5 to 6 carbon atoms. The alkanediol is preferably a 1,2-alkanediol.

[0076] Examples of the alkanediol having 5 to 10 carbon atoms include 1,2-pentanediol, 1,2-hexanediol, 1,2-heptanediol, 1,2-octanediol, 1,2-nonanediol, and 1,2-decanediol. Among these, 1,2-pentanediol, 1,2-hexanediol, and 1,2-octanediol are preferred, 1,2-pentanediol and 1,2-hexanediol are more preferred, and 1,2-pentanediol is even more preferred.

[0077] Commercially available alkanediols having 5 to 10 carbon atoms include HYDROLITE-5, HYDROLITE-5 Green (manufactured by Symrise Co., Ltd.), KMO-6 (manufactured by Osaka Organic Chemical Industry Co., Ltd.), Microcare Emollient PTGJ, and Microcare Emollient HXD (manufactured by THOR).

[0078] The alkanediols having 5 to 10 carbon atoms can be used alone or in combination of two or more.

[0079] The content of 1,2-alkanediol in the composition for external use on skin of the present invention is preferably 0.001% by mass to 20% by mass, more preferably 0.01% by mass to 15% by mass, and even more preferably 0.1% by mass to 10% by mass. When multiple types of alkanediols are contained, the content of alkanediol refers to the total content thereof.

[0080] (Polyhydric alcohol) The skin topical composition of the present invention may further contain a polyhydric alcohol. The polyhydric alcohol used in the skin topical composition of the present invention may be any polyhydric alcohol used in cosmetics, quasi-drugs or medicines without limitation. For example, glycols (ethylene glycol, diethylene glycol, propylene glycol, isopropylene glycol, dipropylene glycol, polypropylene glycol, polyethylene glycol, 1,3-butylene glycol, pentylene glycol, etc.), glycerin, diglycerin, triglycerin, polyglycerin, sorbitol, alkanediols (propanediol, 3-methyl-1,3-butanediol, pentanediol, etc.), etc. may be mentioned. Of these, from the viewpoint of formulation taking into consideration the feel when used, etc., propylene glycol, dipropylene glycol, 1,3-butylene glycol, pentylene glycol, glycerin, diglycerin, sorbitol, alkanediols (propanediol, pentanediol, hexanediol), etc. are preferred, and dipropylene glycol, 1,3-butylene glycol, and pentylene glycol are more preferred.

[0081] The content of the polyhydric alcohol in the composition for external use on skin of the present invention is preferably 0.01% by mass to 99.9% by mass, more preferably 0.1% by mass to 75% by mass, and even more preferably 0.5% by mass to 50% by mass. If it is within the above range, in addition to the effects of the present invention, the composition for external use on skin can be imparted with moisturizing power and a good feeling of use.

[0082] (Glycol Ether) The skin topical composition of the present invention may further contain glycol ether. As the glycol ether used in the skin topical composition of the present invention, those used as glycol ethers in cosmetics, quasi-drugs or pharmaceuticals can be used without limitation. For example, ethylene glycol-based glycol ethers such as ethylene glycol monomethyl ether, ethylene glycol monoethyl ether, and ethylene glycol monopropyl ether; diethylene glycol-based glycol ethers such as diethylene glycol monomethyl ether, diethylene glycol monoethyl ether, and diethylene glycol monopropyl ether; propylene glycol-based glycol ethers such as propylene glycol monoethyl ether and propylene glycol monopropyl ether; and dipropylene glycol-based glycol ethers such as dipropylene glycol monoethyl ether and dipropylene glycol monopropyl ether. Among them, ethylene glycol-based and diethylene glycol-based glycol ethers are preferred, ethylene glycol monomethyl ether and diethylene glycol monoethyl ether are more preferred, and diethylene glycol monoethyl ether is particularly preferred.

[0083] The content of the glycol ether in the topical composition of the present invention is preferably 0.01% by mass to 97% by mass, more preferably 0.1% by mass to 50% by mass, and even more preferably 0.5% by mass to 30% by mass. If it is within the above range, in addition to the effects of the present invention, the topical composition can be imparted with moisturizing power and a good feel when used.

[0084] (Thickener) The skin topical composition of the present invention may further contain a thickener. This allows the skin topical composition to have good skin compatibility and excellent usability. As such a thickener, any thickener used in cosmetics, quasi-drugs, or pharmaceuticals may be used without limitation. For example, agar, gellan gum, guar gum, locust bean gum, carrageenan, xanthan gum, dextran, methylcellulose, ethylcellulose, carboxymethylcellulose, hydroxymethylcellulose, hydroxyethylcellulose, hydroxypropylcellulose, hydroxypropylmethylcellulose, carboxymethylcellulose, carboxyethylcellulose, sodium alginate, propylene glycol alginate, dextran, polyvinyl alcohol, polyvinylpyrrolidone, polyvinyl methyl ether, carboxyvinyl polymer, acrylic acid alkyl methacrylate copolymer, sodium polyacrylate, polyethylene glycol ... Examples of the cellulose acetate include glycol, bentonite, dextrin fatty acid ester, pectin, (hydroxyethyl acrylate / Na acryloyldimethyl taurate) copolymer, dimethyl distearyl ammonium hectorite, (ammonium acryloyldimethyl taurate / vinyl pyrrolidone) copolymer, (ammonium acryloyldimethyl taurate / beheneth-25 methacrylate) cross copolymer, (ammonium acryloyldimethyl taurate / steareth-25 methacrylate) cross polymer, polyethylene glycol distearate, ethylene glycol triisostearate, polyoxyethylene (20) methyl glucoside triisostearate, etc. Among these, methyl cellulose, ethyl cellulose, hydroxyethyl cellulose, hydroxymethyl cellulose, hydroxypropyl cellulose, hydroxypropyl methyl cellulose, carboxymethyl cellulose, carboxyethyl cellulose, xanthan gum, acrylic acid alkyl methacrylate copolymer, (hydroxyethyl acrylate / Na acryloyldimethyl taurate) copolymer, and (ammonium acryloyldimethyl taurate / vinyl pyrrolidone) copolymer are more preferred.

[0085] The content of the thickener in the topical composition of the present invention is preferably 0.0001% by mass to 20% by mass, more preferably 0.001% by mass to 10% by mass, and even more preferably 0.05% by mass to 5% by mass. If the content of the thickener is within the above range, the topical composition for skin can be made to have good compatibility with the skin and excellent usability.

[0086] (Other Ingredients) In addition to the above-mentioned components, the skin topical composition of the present invention may contain one or more of various components such as ultraviolet scattering components, ultraviolet absorbing components, components having a DNA damage prevention and / or repair effect, brightening components, anti-inflammatory components, cell activation components, astringent components, antioxidant components, anti-aging components, moisturizing components, keratin softening components, and blood circulation promoting components in combination in order to add other useful effects. These components are not particularly limited as long as they can be used in the fields of medicines, quasi-drugs, cosmetics, etc., and any one can be appropriately selected and used. In addition, components that fall under the following multiple components can be added as components with any of the effects.

[0087] Examples of the ultraviolet scattering component include inorganic compounds such as zinc oxide, titanium oxide, iron oxide, cerium oxide, zirconium oxide, titanium silicate, zinc silicate, anhydrous silicic acid, cerium silicate, and hydrous silicic acid, and inorganic compounds coated with inorganic powders such as hydrous silicic acid, aluminum hydroxide, mica, and talc, or composites with resin powders such as polyamide, polyethylene, polyester, polystyrene, and nylon, and compounds treated with silicone oil, fatty acid aluminum salt, etc. Among these, inorganic compounds such as zinc oxide, titanium oxide, and iron oxide, and inorganic compounds coated with inorganic powders such as aluminum hydroxide, hydrous silicic acid, mica, and talc, or silicone oil are preferred.

[0088] Examples of the ultraviolet absorbing component include 2-ethylhexyl paramethoxycinnamate, 2-[4-(diethylamino)-2-hydroxybenzoyl]benzoic acid hexyl ester, 2,4,6-tris[4-(2-ethylhexyloxycarbonyl)anilino]-1,3,5-triazine, 2-ethylhexyl dimethoxybenzylideneoxoimidazolidinepropionate, and 2,4-bis-[{4-(2-ethylhexyloxy)-2-hydroxy}-phenyl]-6-(4-methoxyphenyl)-1,3,5-triazine.

[0089] Examples of the brightening ingredient include hydroquinone, placenta, arbutin, kojic acid, ellagic acid, phytic acid, tranexamic acid, 4-n-butylresorcinol, chamomile extract, vitamins such as vitamin A or a derivative thereof, and pantothenic acid or a derivative thereof. Furthermore, plant ingredients having a whitening effect may be used as the whitening ingredient. Examples of such plant ingredients include iris, almond, aloe, ginkgo, oolong tea, Chinese laurel, Scutellaria baicalensis, Coptis chinensis, Hypericum perforatum, white lamb's foot, seaweed, pueraria root, gardenia, lily of the valley, chlorella, barley, rice, rice hyacinth, oryzanol, rice bran, Chinese laurel, Japanese pepper, perilla, peony, cnidium officinalis, soybean, natto, tea, angelica tree, calendula officinalis, garlic, witch hazel, safflower, peonies, coix seed, angelica tree, amethyst, astragalus, andromeda japonica, Japanese laurel, Japanese laurel, Japanese hackberry, persimmon (Diospyros kaki), Japanese laurel, ... Examples of ingredients that can be used include those derived from kaki, catalpa, black bean, gentian, gentian, salsa, kidney bean, jūrou, sage, zenko, radish, azalea, horsetail, toshin, bittern, parsley, holly, hops, Japanese bush clover, clove, licorice, and grapefruit.Preferably, iris, aloe, ginkgo, oolong tea, Chinese laurel, Scutellaria, Coptis, Hypericum, Lamium, seaweed, pueraria, gardenia, kudzu, gobaisha, wheat, rice, rice bran, saishin, Japanese pepper, perilla, peony, cnidium, sophora rhizome, tea, angelica, calendula, hamamelis, safflower, peonies, coix seed, amethyst, acacia, enoki, persimmon (Diospyros kaki), catalpa, black bean, gentian, salsa, green bean, jūrou, sage, zenko, radish, azalea, bush clover, toshin, bitter gourd, parsley, holly, hops, clove, licorice, grapefruit and angelica are derived from these, and more preferred are ingredients derived from iris, aloe, ginkgo, azalea, scutellaria, coptis, hypericum, gardenia, sophora jasmine, rice, rice bran, saishin, peony, cnidium, mulberry, tea, angelica, calendula, hamamelis, safflower, moutan tree, amethyst, acacia, enoki mushroom, kaki (Diospyros kaki), sage, radish, azalea, parsley, hops, licorice, grapefruit and coix seed. Among these, iris root extract, which is an ingredient derived from iris, and brown algae extract, Laminaria serrata extract, and aloe extract, which are ingredients derived from seaweed, are more preferred. When these plant ingredients are used in the topical composition of the present invention, the form of the plant ingredient is not particularly limited, but they can usually be used in the form of a plant extract (plant extract) or essential oil. The parentheses in the above plant ingredients indicate the scientific name, alternative name, or herbal medicine name of the plant.

[0090] Examples of the anti-inflammatory ingredient include allantoin, calamine, tranexamic acid, glycyrrhizic acid or its derivatives or salts thereof, glycyrrhetinic acid or its derivatives or salts thereof, zinc oxide, guaiazulene, tocopherol acetate, pyridoxine hydrochloride, menthol, camphor, turpentine oil, indomethacin, salicylic acid or its derivatives, etc. Preferred are glycyrrhizic acid or its derivatives or salts thereof (e.g., dipotassium glycyrrhizinate, etc.), glycyrrhetinic acid or its derivatives or salts thereof, or zinc oxide.

[0091] Examples of the cell activating components include amino acids such as γ-aminobutyric acid and ε-aminocaproic acid; α-hydroxy acids such as glycolic acid and lactic acid; tannins, flavonoids, saponin, allantoin, photosensitizer No. 301, and the like.

[0092] Examples of the astringent component include metal salts such as alum, chlorohydroxyaluminum, aluminum chloride, aluminum allantoin salt, zinc sulfate, and potassium aluminum sulfate; and organic acids such as tannic acid, citric acid, lactic acid, and succinic acid.

[0093] Examples of the antioxidant components include butylhydroxyanisole, dibutylhydroxytoluene, sodium bisulfite, sodium pyrosulfite, flavonoids, glutathione, glutathione peroxidase, glutathione-S-transferase, catalase, superoxide dismutase, thioredoxin, taurine, thiotaurine, hypotaurine, L-cysteine ​​hydrochloride, and astaxanthin.

[0094] Examples of the anti-aging ingredients include pangamic acid, ursolic acid, turmeric extract, sphingosine derivatives, silicon, silicic acid, N-methyl-L-serine, and mevalonolactone.

[0095] Examples of the moisturizing components include amino acids and derivatives thereof, such as alanine, serine, leucine, isoleucine, threonine, glycine, trimethylglycine, proline, hydroxyproline, glucosamine, and theanine; polyhydric alcohols, such as glycerin; sugar alcohols, such as sorbitol; phospholipids, such as lecithin and hydrogenated lecithin; NMF-derived components, such as lactic acid, sodium pyrrolidone carboxylate, and urea; and plant-derived components, such as lavender oil and Salicornia herbacea extract.

[0096] Examples of the keratin softening ingredient include lanolin, urea, phytic acid, lactic acid, lactate salts, glycolic acid, salicylic acid, malic acid, and citric acid.

[0097] Examples of the blood circulation-promoting component include components derived from plants (e.g., ginseng, angelica, arnica, ginkgo, fennel, Japanese oak, Dutch oak, chamomile, Roman chamomile, carrot, gentian, burdock, rice, hawthorn, shiitake mushroom, European hawthorn, European juniper, cnidium rhizome, Swertia japonica, thyme, clove, tangerine peel, angelica tree, peach kernel, spruce, carrot, garlic, butcher's broom, grape, peony, horse chestnut, melissa, yuzu, coix seed, rosemary, rose hip, tangerine peel, angelica tree, spruce, peach, apricot, walnut, corn); tocopherol nicotinate, glucosyl hesperidin, and hesperidin.

[0098] In addition to the above-mentioned components, the topical composition of the present invention may be appropriately blended with additives that are commonly used in the fields of pharmaceuticals, quasi-drugs, cosmetics, etc., depending on the application or dosage form. The additives that can be blended are not particularly limited, but for example, surfactants, preservatives, pH adjusters, chelating agents, stabilizers, irritation reducers, colorants, dispersants, fragrances, etc. can be blended. These components can be blended alone or in any combination of two or more. The amount of these components to be used can be appropriately determined from the conventionally known ranges within a range that does not impair the effects of the present invention.

[0099] Examples of the surfactant include sorbitan esters such as sorbitan stearate, PEG sorbitan stearate, sorbitan monooleate, sorbitan monoisostearate, and sorbitan monolaurate; POE-sorbitan monooleate; polyoxyethylene hydrogenated castor oil (HCO-10); glycerin fatty acid esters such as glycerin monooleate, glycerin monostearate, and glycerin monomyristate; glycerin alkyl ethers such as monoisostearyl glyceryl ether and monomyristyl glyceryl ether; various nonionic surfactants such as polyglycerin fatty acid esters such as polyglyceride stearate, polyglyceryl-10 isostearate, diglyceryl monostearate, decaglyceryl decastearate, decaglyceryl decastearate, and diglyceryl diisostearate; and naturally derived surfactants such as lecithin, hydrogenated lecithin, saponin, sodium surfactin, cholesterol, and bile acid.

[0100] Examples of the preservatives include benzoic acid, sodium benzoate, dehydroacetic acid, sodium dehydroacetate, isobutyl parahydroxybenzoate, isopropyl parahydroxybenzoate, butyl parahydroxybenzoate, ethyl parahydroxybenzoate, propyl parahydroxybenzoate, benzyl parahydroxybenzoate, methyl parahydroxybenzoate, and phenoxyethanol.

[0101] Examples of the pH adjuster include inorganic acids (hydrochloric acid, sulfuric acid, etc.), organic acids (lactic acid, sodium lactate, citric acid, sodium citrate, succinic acid, sodium succinate, etc.), inorganic bases (potassium hydroxide, sodium hydroxide, etc.), and organic bases (triethanolamine, diisopropanolamine, triisopropanolamine, etc.).

[0102] Examples of the chelating agent include ethylenediaminetetraacetic acid (edetic acid), ethylenediaminetetraacetate (sodium salt (sodium edetate: Japanese Pharmacopoeia, EDTA-2Na, etc.), potassium salt, etc.), phytic acid, gluconic acid, polyphosphoric acid, metaphosphoric acid, etc. Among these, sodium edetate is preferred.

[0103] Examples of the stabilizer include magnesium sulfate, sodium polyacrylate, dibutylhydroxytoluene, and butylhydroxyanisole.

[0104] Examples of the irritation reducer include licorice extract, gum arabic, polyvinylpyrrolidone, sodium alginate, and the like.

[0105] The coloring agent includes inorganic pigments, natural dyes, and the like.

[0106] Examples of the dispersant include sodium pyrophosphate, sodium hexametaphosphate, polyvinyl alcohol, polyvinylpyrrolidone, methyl vinyl ether / maleic anhydride crosslinked copolymer, and organic acids.

[0107] [pH] The composition for external use on the skin of the present invention may generally have a liquid pH of 2.0 to 9.0, but from the viewpoints of low irritation to the skin and mucous membranes and good feel on the skin, the pH is preferably 3.0 to 8.5, and more preferably 3.5 to 8.0.

[0108] [Properties / Formulation] The properties of the skin external composition of the present invention are not particularly limited, and can be liquid, fluid, or semi-solid.The formulation form can be, for example, liquid, suspension, emulsion, cream, milky lotion, ointment, gel, liniment, lotion, or sheet of nonwoven fabric impregnated with drug solution.Among them, emulsion, cream, milky lotion, ointment, gel, and lotion are preferred, and cream, milky lotion, ointment, and gel are particularly preferred.

[0109] The container for filling the skin topical composition of the present invention can be any container of a known shape without any restrictions. The material of the container is also not particularly limited, and the composition can be filled and provided in a container made of a material such as plastics, such as polyethylene terephthalate, polyethylene naphthalate, polyarylate, polycarbonate, polyethylene, or polypropylene, or glass.

[0110] <Method of manufacturing the composition for external use on skin> The skin external composition of the present invention can be produced by appropriately selecting and blending (A) hyaluronic acid fermentation product, (B) hyaluronic acid with a weight-average molecular weight of 1.2 million or less, and other components as mentioned above.The method for producing the skin external composition of the present invention is not particularly limited, and can be produced by appropriately selecting (A) hyaluronic acid fermentation product, (B) hyaluronic acid with a weight-average molecular weight of 1.2 million or less, and other components as mentioned above, and mixing them in a solvent by a conventional method.

[0111] The skin topical composition of the present invention contains (A) hyaluronic acid fermentation product and (B) hyaluronic acids with a weight-average molecular weight of 1.2 million or less, and thus can significantly promote the skin permeability of hyaluronic acid, hyaluronic acid derivatives and / or their salts, and can provide excellent skin softness, moisturizing feeling, and other usability.The skin topical composition of the present invention has excellent skin permeability of hyaluronic acids and also improves the above-mentioned usability, so it can be suitably used in the fields of cosmetics, quasi-drugs and pharmaceuticals.

[0112] <Skin penetration enhancer> The present invention also includes a skin permeation enhancer for hyaluronic acid, hyaluronic acid derivatives, or their salts, which is characterized by containing (A) hyaluronic acid fermentation product and (B) hyaluronic acids with a weight-average molecular weight of 1.2 million or less.The skin permeation enhancer of the present invention contains (A) hyaluronic acid fermentation product and (B) hyaluronic acids with a weight-average molecular weight of 1.2 million or less, and can significantly enhance the permeability of hyaluronic acid, hyaluronic acid derivatives, and / or their salts (hyaluronic acids) into the skin, and can also provide excellent usability such as skin softness and moisturizing feeling.The skin permeation enhancer of the present invention may contain various optional components other than (A) hyaluronic acid fermentation product and (B) hyaluronic acids, within a range that does not impair the effects of the present invention, or for the purpose of improving the effects of the present invention.

[0113] In addition, the skin penetration enhancer of the present invention can also be said to be a combination of (A) a hyaluronic acid fermentation product and (B) hyaluronic acids.

[0114] Since the skin penetration enhancer of the present invention is one embodiment of the above-mentioned composition for external use on the skin of the present invention, the specific description thereof can be applied as is to the section on the composition for external use on the skin.

[0115] The present invention also includes a skin permeation enhancer for hyaluronic acid, a hyaluronic acid derivative, or a salt thereof, which contains (A) a hyaluronic acid fermentation product. When the skin permeation enhancer containing (A) a hyaluronic acid fermentation product is blended with a skin topical composition containing hyaluronic acids, the skin permeability of the hyaluronic acids is significantly enhanced.

[0116] <Method for promoting skin penetration> The present invention also includes a method for promoting skin penetration of hyaluronic acid, hyaluronic acid derivatives, or salts thereof, which is characterized by using (A) a hyaluronic acid fermentation product, and (B) hyaluronic acids having a weight-average molecular weight of 1.2 million or less. By applying to the skin a composition for external use containing (A) a hyaluronic acid fermentation product, and (B) hyaluronic acids having a weight-average molecular weight of 1.2 million or less, it is possible to significantly promote the skin permeability of hyaluronic acid, hyaluronic acid derivatives, and / or salts thereof (hyaluronic acids), and also to provide excellent skin softness, moisturizing feeling, and other usability.

[0117] The method for enhancing skin permeation of the present invention can also be said to be a method for enhancing the permeation of hyaluronic acids into the skin by using the above-mentioned composition for external use on the skin of the present invention.

[0118] The present invention also includes a method for promoting skin permeation of hyaluronic acid, hyaluronic acid derivatives, or their salts by using (A) hyaluronic acid fermentation product. According to the method of the present invention, by incorporating (A) hyaluronic acid fermentation product into a skin topical composition containing hyaluronic acids, the skin permeability of hyaluronic acids can be significantly promoted. EXAMPLES

[0119] The present invention will be described in more detail below based on examples, but the present invention is not limited to these examples.

[0120] 1. Hyaluronic acid permeability evaluation test 1 [Preparation of topical skin composition] According to the recipes shown in Table 1 below, each composition (test solution) was prepared by a conventional method. The units of values ​​in each table are mass (%). The sodium hyaluronate, hydrolyzed sodium hyaluronate, and hydrolyzed alkyl (C12-13) glyceryl hyaluronate in each test solution in Table 1 were fluoresceinamine-labeled.

[0121] [Table 1]

[0122] [Evaluation of hyaluronic acid permeability] Each test solution was applied to the surface of a 3D cultured skin model (LabCyte EPI-MODEL12, manufactured by Japan Tissue Engineering Co., Ltd.) and left to stand for 30 minutes under closed conditions. The surface of the skin model was then washed with phosphate-buffered saline to remove the test solution remaining on the surface. The tissue of the skin model was fixed in formalin for 24 hours, and images of the tissue pieces were taken using a fluorescent microscope. The results are shown in Figures 1-1 to 3-2.

[0123] As shown in Figures 1-1 to 3-2, it was found that the skin permeability of the sodium hyaluronate, hydrolyzed hyaluronic acid, and hydrolyzed alkyl (C12-13) glyceryl hyaluronate in each test solution was significantly improved by adding hyaluronic acid fermentation product.

[0124] 2. Hyaluronic acid permeability evaluation test 2 [Preparation of topical skin composition] Each composition (test solution) was prepared by a conventional method according to the recipe shown in the following Table 2. The units of values ​​in each table are mass (%).

[0125] [Table 2]

[0126] [Evaluation of hyaluronic acid permeability] A panel of six experts evaluated the survivability of each composition according to the evaluation criteria. The evaluation results are shown in Table 2.

[0127] (Assessment of Survivability) Apply 1g of each composition to 10cm of the arm. 2 The composition was applied to the area of ​​100 mm. The composition was applied for 1 minute, and the remaining composition on the applied surface was evaluated. A score of 1 was given when no remaining composition was felt, and a score of 7 was given when a strong remaining composition was felt. The average of the scores given by the expert panel was regarded as the remaining composition of each composition.

[0128] As shown in Table 2, the composition containing sodium hyaluronate with a weight-average molecular weight of 1.2 million and hyaluronic acid fermentation product was perceived to have lower residual properties than the composition containing sodium hyaluronate with a weight-average molecular weight of 1.2 million. This suggests that the sodium hyaluronate with a weight-average molecular weight of 1.2 million in the composition has increased skin permeability due to the incorporation of hyaluronic acid fermentation product.

[0129] 3. Hyaluronic acid permeability evaluation test 3 [Preparation of topical skin composition] Each composition (test solution) was prepared by a conventional method according to the formulation shown in the following Table 3. The units of values ​​in each table are mass (%).

[0130] [Table 3]

[0131] [Evaluation of hyaluronic acid permeability] A panel of three experts evaluated the penetration feel of each composition according to the evaluation criteria. The evaluation results are shown in Table 3.

[0132] (Skin softness evaluation) 2 g of each composition was applied to the arm with a finger. After application, the applied area was pressed with a finger to evaluate the softness of the skin. In comparison with the unapplied part of the arm, a score of 1 was given for no feeling of softness at all, and a score of 7 for the most soft feeling. The average of the scores given by the expert panel was regarded as the softness of the skin. Evaluations were made immediately after application and 2 minutes after application, and the results are shown in Table 3.

[0133] (Evaluation of Moisture Sensation) Apply 1g of each composition to 12cm of your arm. 2 The compositions were applied to the area of ​​the skin. The compositions were applied for 1 minute, and the moist feeling of the applied surface was evaluated. A score of 1 was given when no moist feeling was felt, and a score of 7 was given when a strong moist feeling was felt. The average of the scores given by the expert panel was regarded as the moist feeling of each composition.

[0134] As shown in Table 3, the composition containing sodium hyaluronate with a weight-average molecular weight of 1.2 million, sodium hydrolyzed hyaluronate with a weight-average molecular weight of 10,000, alkyl (C12-13) glyceryl hydrolyzed hyaluronate with a weight-average molecular weight of 10,000, and fermented hyaluronic acid promotes skin softness and moisturization.From this, it is considered that sodium hyaluronate with a weight-average molecular weight of 1.2 million, sodium hydrolyzed hyaluronate with a weight-average molecular weight of 10,000, alkyl (C12-13) glyceryl hydrolyzed hyaluronate with a weight-average molecular weight of 10,000, and fermented hyaluronic acid in the composition has enhanced skin permeability. [Industrial Applicability]

[0135] The topical skin composition of the invention contains (A) a hyaluronic acid fermentation product, and (B) hyaluronic acid, a hyaluronic acid derivative, or a salt thereof having a weight-average molecular weight of 1.2 million or less, and thereby can significantly promote the permeability of the hyaluronic acid, the hyaluronic acid derivative, and / or a salt thereof into the skin, and can also provide excellent usability such as skin softness and moisturization.

Claims

1. (A) a hyaluronic acid fermentation product, and (B) Hyaluronic acid, hyaluronic acid derivatives, or salts thereof having a weight-average molecular weight of 1.2 million or less A composition for external use on the skin comprising:

2. The composition for external skin application according to claim 1, wherein (A) the hyaluronic acid fermentation product is a fermentation product of hyaluronic acid by lactic acid bacteria.

3. The composition for external use on the skin according to claim 1 or 2, comprising at least hydrolyzed alkyl (C12-13) glyceryl hyaluronate, hydroxypropyltrimonium hyaluronate, and sodium acetylated hyaluronate as component (B).

4. (A) a hyaluronic acid fermentation product, and (B) A skin penetration enhancer for hyaluronic acid, a hyaluronic acid derivative, or a salt thereof, which contains hyaluronic acid, a hyaluronic acid derivative, or a salt thereof having a weight-average molecular weight of 1.2 million or less.

5. The skin penetration enhancer according to claim 4, wherein (A) the hyaluronic acid fermentation product is a fermentation product of hyaluronic acid by lactic acid bacteria.

6. (A) a hyaluronic acid fermentation product, and (B) A method for promoting skin penetration of hyaluronic acid, a hyaluronic acid derivative, or a salt thereof, which is characterized by using hyaluronic acid, a hyaluronic acid derivative, or a salt thereof having a weight-average molecular weight of 1.2 million or less.

Citation Information

Patent Citations

  • Super natural yeast composition, and preparation method and application thereof in cosmetics

    CN107822945A

  • Method for producing low-molecular weight hyaluronic acid

    JP2006271351A

  • Liquid cosmetic

    JP2016098185A

  • Emulsion cosmetic

    JP2016199515A

  • Oral composition and external composition for skin

    JP2019156821A